retatrutide effects clinical trial retatrutide Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP retatrutide clinical trial retatrutide drug

In contrast, there is a growing concern that GLP-1RA may be linked to increased risk of suicidal ideation and self-injury (SIS), following reports of the Icelandic Medicines Agency in July 2023 identifying a disproportionate number of cases of SIS in individuals taking liraglutide and semaglutide

Last updated 9/2025

Beyond Mazdutide and Retatrutide, several additional multi-receptor agonists progress through clinical development

Bodybuilding Health + provides access to compounded GLP-1 medications prepared by licensed U.S

GLP-1RA can inhibit the progression of atherosclerosis in the early phase by regulation of immune cell phenotypes

Many women notice weight changes during life stages such as perimenopause or menopause, when traditional diet and exercise efforts may feel less effective